Clinical Trials Browser

Terminated × Observational × lenvatinib × Clear all

NCT04428437 2023-10-05

Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors

Gastrointestinal

Carcinoma, Hepatocellular